# Pharmacological Effects of Crushing Prasugrel in STEMI Patients

> **NCT02212028** · PHASE4 · COMPLETED · sponsor: **University of Florida** · enrollment: 52 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** prasugrel

## Key facts

- **NCT ID:** NCT02212028
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2016-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02212028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02212028, "Pharmacological Effects of Crushing Prasugrel in STEMI Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02212028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*